A
Anders Niklason
Researcher at Bristol-Myers Squibb
Publications - 1
Citations - 1991
Anders Niklason is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Randomized controlled trial & Clinical endpoint. The author has an hindex of 1, co-authored 1 publications receiving 1966 citations.
Papers
More filters
Journal ArticleDOI
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
Lennart Hansson,Lars H Lindholm,Leo Niskanen,Jan Lanke,Thomas Hedner,Anders Niklason,Kimmo Luomanmäki,Björn Dahlöf,Ulf de Faire,Claes Mörlin,Bengt E. Karlberg,P. O. Wester,Jan-Erik Björck +12 more
TL;DR: Captopril and conventional treatment did not differ in efficacy in preventing cardiovascular morbidity and mortality and the difference in stroke risk was probably due to the lower levels of blood pressure obtained initially in previously treated patients randomised to conventional therapy.